New amfAR Funding Opportunity on HIV Persistence and Eradication PDF Print E-mail
Written by Rowena Johnston   
Tuesday, 04 October 2011 16:34

New amfAR Funding Opportunity

amfarLogoThe Foundation for AIDS Research announces request for proposals for grants pertaining to HIV persistence and eradication. These grants are larger and run for longer than amfAR’s usual grants: $250k for 2 years.

  

Targeted Request for Proposals (RFP):

Exploring the mechanisms for HIV persistence and the potential for HIV eradication


For complete details: click here

 

Eligibility: Doctoral-level investigators at nonprofit institutions worldwide


Available Funding: $250,000 Total Costs ($208,333 maximum direct costs plus up to 20% for indirect costs)


Performance Period: Two years starting February 1, 2012.


Deadline: Letters of Intent must be submitted no later than October 25, 2011


Background: This RFP solicits proposals relevant to exploring the mechanisms for HIV persistence and the potential for HIV eradication. Highly active antiretroviral therapy (HAART) has significantly impacted the health of individuals infected with HIV-1. However, if therapy is interrupted, there is a rapid resumption of viral replication. Understanding the mechanisms by which the virus is able to persist in the face of therapy is necessary in order to identify strategies that may interrupt viral persistence and ultimately lead to viral eradication. amfAR wishes to support basic, clinical, and especially translational research exploring the mechanisms whereby HIV infection persists; the chronic nature of viral reservoirs and latency; and barriers to the eradication of HIV, with the potential goal of ultimately eliminating HIV infection. 

 

If you are not able to access the RFP, please e-mail This e-mail address is being protected from spambots. You need JavaScript enabled to view it for assistance.



Key words: HIV cure, HIV eradication, HIV persistence, HIV research, amfAR, request for proposal RFP
Last Updated on Tuesday, 04 October 2011 16:53
 
Comments closed!